Skip to content

Biohaven started at buy by Piper Jaffray

June 22, 2017

Research analysts at Piper Jaffray Companies began coverage on shares of Biohaven Pharmaceutical Holding Co Ltd (NASDAQ:BHVN) in a research note issued on Tuesday, May 30th, MarketBeat reports. The firm set an “overweight” rating and a $21.00 price target on the stock.

http://bit.ly/2rG8ezR

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: